Aytu Biopharma (AYTU) Receivables - Net (2015 - 2026)
Aytu Biopharma (AYTU) posted quarterly Receivables - Net of $24.5 million for Q1 2026, down 31.64% year-over-year from $35.8 million in Q1 2025, and down 20.81% quarter-over-quarter from $30.9 million in Q4 2025.
Aytu Biopharma (AYTU) Receivables - Net (2015 - 2026) Analysis & Trends
Aytu Biopharma (AYTU) has reported Receivables - Net for 12 consecutive years, with $24.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Receivables - Net fell 31.64% year-over-year to $24.5 million; the TTM figure through Mar 2026 stood at $24.5 million (down 31.64% YoY), while the FY2025 annual figure was $32.3 million, up 27.6% from the prior year.
- Receivables - Net retreated to $24.5 million in Q1 2026 per AYTU's latest filing, from $30.9 million in the prior quarter.
- Across five years, Receivables - Net topped out at $35.8 million in Q1 2025 and bottomed at $23.2 million in Q3 2024.
- Historically, Receivables - Net has averaged $28.7 million across 5 years, with a median of $29.4 million in 2023.
- Annual changes were most pronounced in 2025 — Receivables - Net jumped 43.46% — and 2026, when it tumbled 31.64%.
- Aytu Biopharma's Receivables - Net stood at $25.5 million in 2022, then increased by 15.29% to $29.4 million in 2023, then retreated by 13.6% to $25.4 million in 2024, then climbed by 21.73% to $30.9 million in 2025, then slipped by 20.81% to $24.5 million in 2026.
- Business Quant data shows AYTU's Receivables - Net at $24.5 million in Q1 2026, $30.9 million in Q4 2025, and $33.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - |
| 10 | Aytu Biopharma | 24.60 Mn | -2.12 Mn | 7.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 24.49 Mn |
| Mar 31, 2026 | 24.49 Mn |
| Dec 31, 2025 | 30.92 Mn |
| Dec 31, 2025 | 30.92 Mn |
| Sep 30, 2025 | 33.23 Mn |
| Sep 30, 2025 | 33.23 Mn |
| Jun 30, 2025 | 31.16 Mn |
| Jun 30, 2025 | 31.16 Mn |
| Mar 31, 2025 | 35.83 Mn |
| Mar 31, 2025 | 35.83 Mn |
| Dec 31, 2024 | 25.40 Mn |
| Dec 31, 2024 | 25.40 Mn |
| Sep 30, 2024 | 23.16 Mn |
| Sep 30, 2024 | 23.16 Mn |
| Jun 30, 2024 | 23.53 Mn |
| Jun 30, 2024 | 23.53 Mn |
| Mar 31, 2024 | 29.90 Mn |
| Mar 31, 2024 | 29.90 Mn |
| Dec 31, 2023 | 29.40 Mn |
| Dec 31, 2023 | 29.40 Mn |